Hisani N. Horne

FDA Approval Summary: Rucaparib for the Treatment of Patients with Deleterious <i>BRCA</i> Mutation–Associated Advanced Ovarian Cancer

Sanjeeve Balasubramaniam, Julia A. Beaver, Sara Horton et al. · Clinical Cancer Research · 2017 · 158 citations

FDA Approval Summary: Niraparib for the Maintenance Treatment of Patients with Recurrent Ovarian Cancer in Response to Platinum-Based Chemotherapy

Gwynn Ison, Lynn Howie, Laleh Amiri‐Kordestani et al. · Clinical Cancer Research · 2018 · 125 citations

Effect of patient navigation on colorectal cancer screening in a community-based randomized controlled trial of urban African American adults

Hisani N. Horne, Darcy F. Phelan-Emrick, Craig Evan Pollack et al. · Cancer Causes & Control · 2014 · 75 citations · Full text

Health Care Disparity, Cancer Screening, Medicine +9

Microarray Analysis of Early Stage Serous Ovarian Cancers Shows Profiles Predictive of Favorable Outcome

Andrew Berchuck, Edwin S. Iversen, Jingqin Luo et al. · Clinical Cancer Research · 2009 · 71 citations · Full text

Relationship of Terminal Duct Lobular Unit Involution of the Breast with Area and Volume Mammographic Densities

Gretchen L. Gierach, Deesha A. Patel, Ruth M. Pfeiffer et al. · Cancer Prevention Research · 2015 · 60 citations · Full text

Breast Oncology, Cancer Epidemiology, Medical Imaging +14